These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14675183)

  • 1. HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes.
    Suomela S; Elomaa O; Asumalahti K; Kariniemi AL; Karvonen SL; Peltonen J; Kere J; Saarialho-Kere U
    J Invest Dermatol; 2003 Dec; 121(6):1360-4. PubMed ID: 14675183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mouse models support HCR as an effector gene in the PSORS1 locus.
    Elomaa O; Majuri I; Suomela S; Asumalahti K; Jiao H; Mirzaei Z; Rozell B; Dahlman-Wright K; Pispa J; Kere J; Saarialho-Kere U
    Hum Mol Genet; 2004 Aug; 13(15):1551-61. PubMed ID: 15190014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes.
    Tiala I; Suomela S; Huuhtanen J; Wakkinen J; Hölttä-Vuori M; Kainu K; Ranta S; Turpeinen U; Hämäläinen E; Jiao H; Karvonen SL; Ikonen E; Kere J; Saarialho-Kere U; Elomaa O
    J Mol Med (Berl); 2007 Jun; 85(6):589-601. PubMed ID: 17221218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers.
    Suomela S; Cao L; Bowcock A; Saarialho-Kere U
    J Invest Dermatol; 2004 Mar; 122(3):717-21. PubMed ID: 15086558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrhoeic keratosis, Bowen's disease and basal cell carcinoma.
    Morimoto Y; Saga K; Bando M; Takahashi M
    Br J Dermatol; 1991 Jul; 125(1):9-13. PubMed ID: 1831385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin expression in hyperproliferative skin diseases.
    Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
    Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ras proto-oncogene related protein p21 in normal human skin and cutaneous tumours.
    Tanikawa E; Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1992; 93(1):282-9. PubMed ID: 1326835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acantholytic anaplastic Paget's disease.
    Mobini N
    J Cutan Pathol; 2009 Mar; 36(3):374-80. PubMed ID: 19220635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 immunoreactivity in malignant tumours of the skin.
    Bornscheuer E; Schröder JM; Christophers E; Sticherling M
    Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear translocation of ATBF1 is a potential prognostic marker for skin cancer.
    Nishio E; Miura Y; Kawaguchi M; Morita A
    Acta Dermatovenerol Croat; 2012; 20(4):239-45. PubMed ID: 23317484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele.
    Asumalahti K; Laitinen T; Itkonen-Vatjus R; Lokki ML; Suomela S; Snellman E; Saarialho-Kere U; Kere J
    Hum Mol Genet; 2000 Jun; 9(10):1533-42. PubMed ID: 10888604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
    Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ
    J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus.
    Asumalahti K; Veal C; Laitinen T; Suomela S; Allen M; Elomaa O; Moser M; de Cid R; Ripatti S; Vorechovsky I; Marcusson JA; Nakagawa H; Lazaro C; Estivill X; Capon F; Novelli G; Saarialho-Kere U; Barker J; Trembath R; Kere J;
    Hum Mol Genet; 2002 Mar; 11(5):589-97. PubMed ID: 11875053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
    Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
    Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
    Park GT; Seo EY; Lee KM; Lee DY; Yang JM
    Br J Dermatol; 2006 Mar; 154(3):411-8. PubMed ID: 16445768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.